premenstrual%20dysphoric%20disorder
PREMENSTRUAL DYSPHORIC DISORDER
Premenstrual dysphoric disorder is a cyclical disorder presenting with distressing mood and behavioral symptoms that occur during the late luteal phase of the ovulatory cycle; it is a severe form of premenstrual syndrome.
It results in considerable impairment of the patient's personal functioning that occurs in approximately 5% of women of reproductive age.

Premenstrual Dysphoric Disorder Drug Information

Drug Information

Indication: Dysmenorrhoea, endometriosis, secondary amenorrhoea, irregular cycles, dysfunctional uterine bleeding, pre-men...

Indication: Major depressive episode, panic disorder w/ or w/o agoraphobia, social or generalized anxiety disorder, obsess...

Indication: Locally advanced or metastatic prostate cancer. Genital & extragenital stage I-IV endometriosis. Precociou...

Indication: Depression including depression w/ associated anxiety. Generalized anxiety disorder (GAD) including long-term ...

Indication: Premenstruation syndrome, postponement of menstruation, mastodynia, cycle disturbance associated w/ shortening...

Indication: Short-term treatment of moderate or severe anxiety & anxiety associated w/ depression.

Dosage: Anxiety Initially 0.25-0.5 mg tds. Usual dose range: 0.5-4 mg daily. Depression Initially 0.5 mg tds. Usual do

Indication: Dietary supplement.

1  /  8
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Natalia Reoutova, 07 May 2020

A Chinese cross-sectional case-control study has identified time spent following news on coronavirus disease 2019 (COVID-19) and drug-resistant epilepsy as two independent predictors of severe psychological distress among epilepsy patients during the COVID-19 pandemic.